Compound ID | 2272
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against spore-forming clostridia and bacilli |
| Description: | Natural product from a faecal sample Bacillus thuringiensis; compares favourably to metronidazole when tested on ex vivo distal colon C. difficile 001 infection model; does not kill beneficial Gram-positives in gut (ex. Lactobacillus casei 338 or Bifidobacterium lactis Bb12); two-component bacteriocin |
| Year first mentioned: | 2010 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|
| Patent: | JP2011505126A |